Altimmune (ALT) FCF Margin (2010 - 2025)
Altimmune's (ALT) quarterly FCF Margin came in at 74803.85% in Q4 2025, up 29049615.0% year-on-year from N/an in Q4 2024, and up 68.56% on a QoQ basis from 237940.0% in Q3 2025.
Altimmune (ALT) FCF Margin (2010 - 2025) Analysis & Trends
Altimmune (ALT) has 16 years of FCF Margin data on file, last reported at 74803.85% in Q4 2025.
- On a quarterly basis, FCF Margin rose 29049615.0% year-over-year to 74803.85% in Q4 2025; TTM through Dec 2025 was 164721.95%, a 23451805.0% increase from a year earlier, with the FY2025 full-year figure at 164746.34%, up 23449366.0% from the prior year.
- FCF Margin for Q4 2025 stood at 74803.85%, up from 237940.0% in the prior quarter.
- Over the last five years, FCF Margin for ALT reached as high as 674.82% in Q4 2021 and fell as low as 755500.0% in Q3 2022.
- Historically, FCF Margin has averaged 210363.27% across 5 years, with a median of 150847.32% in 2023.
- Across the five-year window, FCF Margin sank 74420570 bps in 2022 and jumped 74984061 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 674.82% in 2021, then sank by 9785 bps to 66707.69% in 2022, then soared by 33 bps to 44683.78% in 2023, then tumbled by 718 bps to 365300.0% in 2024, then jumped by 80 bps to 74803.85% in 2025.
- Per Business Quant data, the three most recent FCF Margin figures were 74803.85% in Q4 2025, 237940.0% in Q3 2025, and 387000.0% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -74,803.85% |
| Sep 30, 2025 | -237,940.00% |
| Jun 30, 2025 | -387,000.00% |
| Mar 31, 2025 | -336,800.00% |
| Dec 31, 2024 | -365,300.00% |
| Sep 30, 2024 | -542,360.00% |
| Jun 30, 2024 | -362,160.00% |
| Mar 31, 2024 | -327,140.00% |
| Dec 31, 2023 | -44,683.78% |
| Sep 30, 2023 | -5,659.39% |
| Jun 30, 2023 | -322,983.33% |
| Mar 31, 2023 | -92,657.14% |
| Dec 31, 2022 | -66,707.69% |
| Sep 30, 2022 | -755,500.00% |
| Jun 30, 2022 | -209,037.50% |
| Mar 31, 2022 | -42,296.88% |
| Dec 31, 2021 | -674.82% |
| Sep 30, 2021 | -11,294.30% |
| Jun 30, 2021 | -19,429.20% |
| Mar 31, 2021 | -2,837.47% |